Eton Pharmaceuticals, Inc. (ETON) earnings
ETON earnings moved a median of +0.84% by the close. Quarterly and annual ETON reports and results, each read against the price at its own news timestamp. Back to the ETON overview →
33 measured ETON earnings events.
Where these ETON earnings landedvs 33 measured ETON earnings reactions
| Middle 50% of ETON earnings reactions | -3.75% to +4.20% |
|---|---|
| Median reaction (to close) | +0.84% |
| Measured reactions | 33 |
Point-in-time · zero look-ahead
Half of the 33 ETON earnings events with a measured close landed between -3.75% and +4.20%; 55% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results | Press release | +3.00% | +6.88% | |
| Form 10-Q Eton Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +3.00% | +6.88% | |
| Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 | Press release | -1.91% | -2.97% | |
| Eton Pharmaceuticals Reports First Quarter 2026 Financial Results | Press release | -1.58% | +4.20% | |
| Form 10-Q Eton Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.58% | +4.20% | |
| Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 | Press release | +0.84% | +0.43% | |
| Form 10-K Eton Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -2.64% | +4.30% | |
| Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results | Press release | -5.49% | -11.70% | |
| Form 10-Q Eton Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -5.49% | -11.70% | |
| Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 | Press release | +0.21% | -1.76% | |
| Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results | Press release | -11.70% | +2.27% | |
| Form 10-Q Eton Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -11.70% | +2.27% | |
| Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025 | Press release | -1.03% | -2.84% | |
| Eton Pharmaceuticals Reports First Quarter 2025 Financial Results | Press release | +7.79% | -9.89% | |
| Form 10-Q Eton Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +7.79% | -9.89% | |
| Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025 | Press release | +2.08% | +1.52% | |
| Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results | Press release | -6.85% | +4.78% | |
| Form 10-K Eton Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -6.85% | +4.78% | |
| Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025 | Press release | -0.40% | +2.08% | |
| Eton Pharmaceuticals Reports Third Quarter 2024 Financial Results | Press release | +6.00% | +6.00% | |
| Form 10-Q Eton Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +6.00% | +6.00% | |
| Eton Pharmaceuticals to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 | Press release | +0.40% | -0.23% | |
| Eton Pharmaceuticals Reports Second Quarter 2024 Financial Results | Press release | -2.74% | +1.92% | |
| Form 10-Q Eton Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -2.74% | +1.92% | |
| Eton Pharmaceuticals to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024 | Press release | +0.00% | +0.84% | |
| Eton Pharmaceuticals Reports First Quarter 2024 Financial Results | Press release | -2.70% | -7.30% | |
| Form 10-Q Eton Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -2.70% | -7.30% | |
| Eton Pharmaceuticals to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024 | Press release | — | -1.13% | |
| Form 10-K/A Eton Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.13% | -1.02% | |
| Form 10-K Eton Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +4.88% | -3.75% | |
| Eton Pharmaceuticals Reports Third Quarter 2023 Financial Results | Press release | +0.95% | -14.48% | |
| Form 10-Q Eton Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.95% | -14.48% | |
| Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023 | Press release | +0.00% | +3.17% |
Keep exploring
More ETON: analyst actions → · SEC filings → · ETON overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | 235 | +0.40% | 57% |
| Equillium, Inc. (EQ) | 234 | 0.00% | 51% |
| THERAPIX BIOSCIENCES LTD AMERICAN DEPOSITARY SHARE (TRPX) | 234 | -1.05% | 31% |
| Catalent, Inc. (CTLT) | 232 | +0.10% | 62% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.